11 HURLEY ST., CAMBRIDGE, MA
Stockholders Elect Bernadette Connaughton and Elliott Levy as Directors
Other Events
Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress
Announces Pricing of Up to $319.4 Million Public Offering
Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting
Announces First Quarter 2026 Results and Business Updates
Annual Report to Security Holders
Change in Accountant - Ernst & Young Dismissed, PwC Appointed
Q1
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Additional Securities
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement
Confidential Treatment Order
SEC Staff Correspondence